NJ-based Johnson & Johnson says COVID-19 vaccine is safe, showing promising immune response
Johnson & Johnson says its COVID-19 vaccine is safe and showing a promising immune response.
•
Jan 14, 2021, 12:19 PM
•
Updated 1,429 days ago
Share:
More Stories
Hometown Heroes in New York City
142ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
438ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
450ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
457ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
471ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
472ds agoHometown Heroes in New York City
142ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
438ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
450ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
457ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
471ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
472ds agoJohnson & Johnson says its COVID-19 vaccine is safe and
showing a promising immune response.
The company has reported few
side effects in early trials, things such as headache, muscle aches, and
soreness.
Data shows most volunteers
developed antibodies after 28 days.
Johnson & Johnson's
vaccine requires only one dose, while Pfizer's and Moderna's require two.
More from News 12
1:45
NYCHA Hylan Houses residents await results of vote on future of development
1:22
Medical examiner: Dumbo human remains all stem from 1 person
1:38
MTA: More accessibility coming to stations in the Bronx
0:23
Off-duty police officer arrested for DWI, refusing to take breath test
1:26
Mother injured in Throgs Neck hit-and-run
1:13
